Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VIVO BIO TECH Share Price   (SSHF)



Here is the latest stock price and chart of VIVO BIO TECH. For more details, see the VIVO BIO TECH company fact sheet and quarterly results. For a sector overview, read our finance sector report.

Must See: Do You Invest in Midcap Stocks? Here's a Great News for You

REFRESH
Live BSE Quotes Apr 22, 2024 12:28:00 PM
Price (Rs)46.00 Open (Rs) 45.70 High (Rs) 47.00 Low (Rs) 44.70
% Change0.90 Volume 10,548 Value (Rs) 485,208 52-Week H/L 56.00 / 21.05
Live NSE Quotes
Not listed
Change
1 Day
0.90%
1 Month
1.30%
3 Months
12.11%
1 Year
86.61%
5 Years (CAGR)*
-2.70%
10 Years (CAGR)*
11.78%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 2.59 P/E Ratio (x) 17.78 Market Cap (Rs m) 685.56 P/BV (x) 1.28 Dividend Yield (%) 0.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

VIVO BIO TECH Share Price Today:

VIVO BIO TECH last traded price was up 0.9% to Rs 46.0 on the BSE. The total volume of shares traded was 0.0 m.

Overall, the benchmark S&P BSE SENSEX was at 73,425.8 (up 0.5%).

Over the last 30 days, the VIVO BIO TECH share price is up 13.0%. And over the last one year, VIVO BIO TECH share price is up 88.6%.

The current market capitalisation of VIVO BIO TECH stands at Rs 685.56 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of March 2024, company promoters held 42.08% stake in VIVO BIO TECH, with no shares having been pledged. To know more, check out the latest shareholding pattern of VIVO BIO TECH.



FAQs on VIVO BIO TECH

What is the VIVO BIO TECH share price today?

The last traded price of VIVO BIO TECH was Rs 46.0 on the BSE, up 0.9% over the previous close.

What is the market cap of VIVO BIO TECH?

The current market capitalisation of VIVO BIO TECH stands at Rs 686 m.

What is the Earnings per share (EPS) of VIVO BIO TECH?

VIVO BIO TECH had an EPS of Rs 2.6 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs 0.9.

What is the PE Ratio and PB Ratio of VIVO BIO TECH?

At the current price of Rs 46.0, VIVO BIO TECH trades at a PE ratio of 17.78 while its PB ratio stands at 1.28.

What is the Dividend Yield of VIVO BIO TECH?

For the financial year 2023, VIVO BIO TECH declared dividend amounting to Rs 0.0 per share. At the current price of Rs 46.0, this results in a dividend yield of 0.0%.

Which are the top finance companies in India by marketcap?

Based on marketcap, these are the top finance companies in India:

You can see the full list of finance stocks ranked by marketcap here.

Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.

Which are the biggest finance companies in India by sales?

Based on sales, these are the top finance companies in India:

You can see the full list of finance stocks.

Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.

Which are the biggest finance companies in India by net profit?

Based on net profit, these are the top finance companies in India:

You can see the full list of finance stocks.

In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.


Today's Market

Sensex Today Trades Higher | Nifty Above 22,250 | IREDA Jumps 10%, Vodafone Idea Drops 4% Sensex Today Trades Higher | Nifty Above 22,250 | IREDA Jumps 10%, Vodafone Idea Drops 4%(10:30 am)

Markets in Asia apart from Shanghai's were broadly higher on Monday, shrugging off the blues on Wall Street after big technology stocks logged their worst week since the COVID crash in 2020.